Tuberculosis: Novel Therapies through Knowledge of the Genetics of the Causative Agent
Tuesday, April 6, 2010 | 1:00 PM - 5:30 PM
Website: http://www.nyas.org/tb
Event Description:
Tuberculosis kills close to two million people each year and infecting strains of Mycobacterium tuberculosis resistant to standard regimens are increasingly more prevalent. There is a clear need for new TB drugs and for new drug discovery paradigms. It has been more than 10 years since the sequence of M. tuberculosis genome was published. The accumulated knowledge from the intervening years, together with recent use of innovative genetic techniques, has shifted the emphasis in TB drug discovery from empirical approaches to hypothesis-driven processes. These new processes can accelerate identification and validation of pharmaceutical targets, unveil resistance mechanisms, and present new compound screening strategies and drug development pathways. This symposium will highlight recent advances in these areas as well as deeper insights into the pathophysiology of the disease that has been enabled by genetic tools.
This event is also available as a live, interactive webinar.
Speakers:
Helena Boshoff, PhD
National Institutes of Health
Carl Nathan, MD
Weill Cornell Medical College
Christopher Sassetti, PhD
University of Massachusetts Medical School
Dirk Schnappinger, PhD
Weill Cornell Medical College
Registration: www.nyas.org/tb
NYAS Members Free
Nonmember $20.00
Nonmember Student $10.00
Location of Event:
The New York Academy of Sciences
7 World Trade Center
250 Greenwich Street, 40th Floor
New York, NY 10007
Map & Directions: www.nyas.org/Directions
Contact Information: For additional info, email nymeetings@nyas.org or call 212.298.3725
Presented by: Emerging Infection Diseases & Microbiology Discussion Group at The New York Academy of Sciences.
Related to project:
When:
April 6, 2010 1:00 pm - 5:30 pm EDT
Where:
The New York Academy of Sciences
250 Greenwich Street, 40th Floor
7 World Trade Center
New York, United States
